Equities
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
LLY:NYQ since
announced
Transaction
value
Ventyx Biosciences IncAnnounced07 Jan 202607 Jan 2026Announced-0.55%1.01bn
Adverum Biotechnologies IncAnnounced24 Oct 202524 Oct 2025Announced28.88%274.32m
Verve Therapeutics IncDeal completed17 Jun 202517 Jun 2025Deal completed31.03%1.25bn
SiteOne Therapeutics IncDeal completed27 May 202527 May 2025Deal completed48.26%1.00bn
Data delayed at least 15 minutes, as of Feb 06 2026 21:00 GMT.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.